Actinogen Medical Health Care
Biotech Healthcare

$0.040 -0.002 (-4.76%)

High $0.04	Low $0.04	Trades 59	Turnover $28,759	Volume 696,012
30 June 2023 at 4:10pm

If you were already registered, log in here.

Market Cap (12-Nov) $174,337,584 (584th)	Close (30-Jun) $0.040 0 (0%)	Volume (30-Jun) 696,012	Shortsold (19-Oct) 10,661 (0.00%) (635th)
52w High $0.072	52w Low $0.031	P/E 25.97	EPS 0

Short Interest

ASIC data, 19 Oct 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

635th

of 711 shorted ASX stocks

Peak Short

1.19%

Apr 2015

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	ACW ACW Ann: ACW CEO presentation on emerging oral Alzheimers therapies
	1 (current) 2 3
	ACW ACW Ann: ACW CEO & CMO present at BIO International Convention
	ACW ACW Ann: ACW AD trial amendment and Clinical Science Forum slides
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: Actinogen CMO presents at ADPD 2023 conference
	ACW ACW Ann: Application for quotation of securities - ACW
	ACW ACW Ann: Appendix 3X - Dr Nicki Vasquez
	ACW ACW Ann: ACW appoints Dr Nicki Vasquez as a Non-Executive Director
	ACW ACW Ann: Actinogen CEO presents to Spark Plus Biotech conference
	ACW ACW Ann: Appendix 4D & Half-Year Financial Statements
	ACW ACW Ann: Actinogen appoints Dr Dana Hilt as Chief Medical Officer
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: ACW CEO presentation Sachs Neuroscience and JPM week
	ACW ACW Ann: Letter to Shareholders - CEO 2022 Review & Outlook
	ACW ACW Ann: FDA agrees to six-month Phase 2b Alzheimers Disease Trial
	ACW ACW Ann: Cleansing Notice
	ACW ACW Ann: Application for quotation of securities - ACW
	ACW ACW Ann: First patient treated in XanaCIDD Phase 2 Depression Trial
	ACW ACW Ann: Actinogen poster presentation at CTAD conference 2022
	ACW ACW Ann: Constitution
	ACW ACW Ann: Results of AGM
	ACW ACW Ann: Actinogen AGM Chair address & CEO presentation
	ACW ACW Ann: Appendix 3Y - Dr George Morstyn
	ACW ACW Ann: Cleansing Notice
	ACW ACW Ann: Application for quotation of securities - ACW
	ACW ACW Ann: ACW CEO presentation to Bell Potter Healthcare Conference
	ACW ACW Ann: Appendix 3Y - Dr Steven Gourlay
	ACW ACW Ann: Actinogen CEO presentation to Spark Plus Healthcare Day
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: Actinogen CEO presentation to ShareCafe investor webinar
	ACW ACW Ann: R&D tax incentive rebate received
	ACW ACW Ann: Annual Report to Shareholders
	ACW ACW Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	ACW ACW Ann: ACW clinical biomarker study webcast presentation
	ACW ACW Ann: ACW announces positive Alzheimers Disease clinical results
	ACW ACW Ann: Trading Halt
	ACW ACW Ann: Date of AGM and Closing Date for Director Nominations
	ACW ACW Ann: Actinogen AD Biomarkers Context & History Presentation
	ACW ACW Ann: Appendix 4G
	ACW ACW Ann: Corporate Governance Statement
	ACW ACW Ann: Actinogen FY22 Results - Accelerating Clinical Development
	ACW ACW Ann: ACW Appendix 4E and 2022 Annual Report
	ACW ACW Ann: Actinogen Spark Plus non deal roadshow investor presentation
	ACW ACW Ann: Actinogen Clinical Trials Science Forum presentation slides
	ACW ACW Ann: ACW CEO presentation to Spark Plus Aust Equities Day
	ACW ACW Ann: Quarterly Activity Report & Appendix 4C
	ACW ACW Ann: ACW CEO to present at Spark Plus Aust Equities Day
	ACW ACW Ann: Actinogen Clinical Trials Science Forum Save the Date
	ACW ACW Ann: Application for quotation of securities - ACW
	ACW ACW Ann: Actinogen Alzheimer Disease Biomarker Study Timing & Design

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

MATRIX CRITICAL MINERALS LIMITED

MTX

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Gratifii

MBM

Top

End of Day Prices

Date	Close	Volume	Change
12-Nov	$0.05	8,468,087	0.00 (4.26%)
11-Nov	$0.05	5,648,328	0.00 (2.08%)
10-Nov	$0.05	7,712,803	0.00 (0.00%)
09-Nov	$0.05	17,159,991	+0.01 (17.07%)
06-Nov	$0.04	8,982,274	0.00 (4.65%)
05-Nov	$0.04	7,148,996	+0.00 (7.50%)
04-Nov	$0.04	2,702,368	0.00 (2.44%)
03-Nov	$0.04	5,818,988	0.00 (0.00%)
02-Nov	$0.04	5,687,078	0.00 (2.38%)
30-Oct	$0.04	5,311,121	0.00 (2.33%)
29-Oct	$0.04	4,384,477	+0.00 (7.50%)
28-Oct	$0.04	931,237	0.00 (2.44%)
27-Oct	$0.04	14,200,759	0.00 (4.65%)
26-Oct	$0.04	6,055,039	0.00 (6.52%)
23-Oct	$0.05	4,991,665	0.00 (2.13%)
3 up, 10 down, and 2 flat days

Actinogen Medical Health Care
Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Actinogen Medical Health Care Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Actinogen Medical Health Care
Biotech Healthcare